Purification and amino acid sequence of MP-III 4R D49 phospholipase A2 from Bothrops pirajai snake venom, a toxin with moderate PLA2 and anticoagulant activities and high myotoxic activity.
MP-III 4R PLA2 was purified from the venom of Bothrops pirajai venom (Bahia's jararacussu) after three chromatographic steps which started with RP-HPLC. The complete amino acid sequence of MP-III 4R PLA2 from Bothrops pirajai was determined by amino acid sequencing of reduced and carboxymethylated MP-III 4R and the isolated peptides from clostripain and protease V8 digestion. MP-III 4R is a D49 PLA2 with 121 amino acid residues and has a molecular weight estimated at 13,800 Da, with 14 half-cysteines. This protein showed moderate PLA2 and anticoagulant activity. This PLA2 does not have a high degree of homology with other bothropic PLA2-like myotoxins (approximately 75%) and nonbothropic myotoxins (approximately 60%). MP-III 4R is a new PLA2, which was isolated using exclusively analytical and preparative HPLC methods. Based on the N-terminal sequence and biological activities, MP-III 4R was identified as similar to piratoxin-III (PrTX-III), which was isolated by conventional chromatography based on molecular exclusion ion exchange chromatography. Clinical manifestations indicate that at the site of toxin injection, there may be pain of variable intensity, because animals continue to lick the limb. No clinical sign indicating general toxicity was noticed. Myotoxicity was observed in gastrocnemius muscle cells after exposure to MP-III 4R, with a high frequency (70%) of affected muscle fibers.
Toyama
M H
MH
Departamento do Bioquímica, Instituto de Biologia, UNICAMP, São Paulo, Brazil.
Costa
P D
PD
Novello
J C
JC
de Oliveira
B
B
Giglio
J R
JR
da Cruz-Höfling
M A
MA
Marangoni
S
S
D000595:Amino Acid Sequence; D000818:Animals; D000925:Anticoagulants / Q000737:chemistry; D017837:Bothrops / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D002852:Chromatography, Ion Exchange; D054501:Group II Phospholipases A2; D051379:Mice; D008969:Molecular Sequence Data; D018482:Muscle, Skeletal / Q000737:chemistry / Q000166:cytology; D010455:Peptides / Q000378:metabolism; D010741:Phospholipases A / Q000737:chemistry* / Q000302:isolation & purification*; D054467:Phospholipases A2; D030162:Reptilian Proteins; D017421:Sequence Analysis; D017386:Sequence Homology, Amino Acid; D012910:Snake Venoms / Q000737:chemistry* / Q000633:toxicity; D013997:Time Factors; D014118:Toxins, Biological / Q000737:chemistry; D014757:Viper Venoms
D000925:Anticoagulants; D010455:Peptides; D030162:Reptilian Proteins; D012910:Snake Venoms; D014118:Toxins, Biological; D014757:Viper Venoms; C121349:MP-III 4R D49 phospholipase A2 protein, Bothrops pirajai; D010741:Phospholipases A; D054501:Group II Phospholipases A2; D054467:Phospholipases A2